Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018:73:e68.
doi: 10.6061/clinics/2018/e68. Epub 2018 Apr 5.

Difficulties in the diagnosis and treatment of rare diseases according to the perceptions of patients, relatives and health care professionals

Affiliations

Difficulties in the diagnosis and treatment of rare diseases according to the perceptions of patients, relatives and health care professionals

Marcos Thomazin Lopes et al. Clinics (Sao Paulo). 2018.

Abstract

Objectives: The aim of this study is to present a survey of vulnerabilities and to suggest approaches for the treatment of rare diseases according to the perceptions of a group of affected individuals, patient association representatives and health care professionals.

Methods: The focus group technique was used in interviews with patients and primary caregivers, patient support groups/non-governmental organizations, primary health care professionals and physician specialists.

Results: The transcript analysis focused on thematic units, which were tailored to each group and allowed comparisons in search of concordant views. Unanimity was observed in relation to the physical, emotional and social damage to the life standards of the affected individuals and their families as a result of illness. The Brazilian health system was unanimously classified as inadequate to respond to the needs of patients with rare diseases, and this inadequacy led to unpleasant experiences, such as the seemingly endless referrals among health services to reach a final diagnosis and develop a treatment plan.

Conclusions: The complex set of health system requirements necessary to support the care of patients with rare diseases represents an obstacle to successfully meeting the needs of patients and their families. Therefore, it is important to develop specific public policies to create referral services, guarantee access to appropriate therapeutic modalities and incorporate technologies that promote research for developing new, affordable therapies.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Similar articles

Cited by

References

    1. Zurynski Y, Frith K, Leonard H, Elliott E. Rare childhood diseases: how should we respond. Arch Dis Child. 2008;93((12)):1071–4. doi: 10.1136/adc.2007.134940. - DOI - PubMed
    1. Guillem P, Cans C, Robert-Gnansia E, Aymé S, Jouk PS. Rare diseases in disabled children: an epidemiological survey. Arch Dis Child. 2008;93((2)):115–8. doi: 10.1136/adc.2006.104455. - DOI - PubMed
    1. Denis A, Mergaert L, Fostier C, Cleemput I, Simoens S. A comparative study of European rare disease and orphan drug markets. Health Policy. 2010;97((2-3)):173–9. doi: 10.1016/j.healthpol.2010.05.017. - DOI - PubMed
    1. Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of presents policies and opportunities for improvement. Rare Dis. 2013;1:e23579. doi: 10.4161/rdis.23579. - DOI - PMC - PubMed
    1. Vieira FS, Zucchi P. Distorções causadas pelas ações judiciais à política de medicamentos no Brasil. Rev Saúde Pública. 2007;41((2)):214–22. - PubMed

Publication types